Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-03

Clinical Trial Update: Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study comparing VI-0521 to placebo for glycemic management in obese patients with Type 2 Diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2012-09-03